Jim Simons acquired 770 Thousand Sage Therapeutics shares worth $7.08 Million. That's 0.01% of their equity portfolio (1195th largest holding). The investor owns 1.24% of the outstanding Sage Therapeutics stock. The first Sage Therapeutics trade was made in Q1 2015. Since then Jim Simons bought shares nine more times and sold shares on eleven occasions. The investor's estimated purchase price is $8.63 Million, resulting in a loss of 18%.